Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet SyndromeCLINICAL THERAPEUTICSIF3.62021-11-018PREAI
Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology AppraisalADVANCES IN THERAPYIF42019-12-2127OAAI
A REVIEW OF APPRAISAL TIMELINES IN ONCOLOGY: DOES REIMBURSEMENT THROUGH THE CANCER DRUGS FUND (CDF) DELAY PATIENT ACCESS?VALUE IN HEALTHIF62018-10-010OAAI
A REVIEW OF THE INFLUENCE OF INTERNATIONAL REFERENCE PRICING (IRP) ON LAUNCH SEQUENCING IN EUROPEVALUE IN HEALTHIF62018-10-010OAAI
Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)EUROPEAN RESPIRATORY JOURNALIF212016-11-081PRE
DISEASE PROGRESSION MODELLING IN IDIOPATHIC PULMONARY FIBROSIS: A PREDICTION OF TIME TO DISEASE PROGRESSION AND LIFE EXPECTANCY WITH PIRFENIDONETHORAXIF7.72015-11-120OAAI
TRENDS IN THE USE OF COST-MINIMIZATION ANALYSIS IN ECONOMIC ASSESSMENTS SUBMITTED TO THE SMCVALUE IN HEALTHIF62015-05-013OAAI
HOW DOES A SMALL OR MEDIUM SIZED PHARMACEUTICAL COMPANY PREPARE FOR AND NAVIGATE THE SCOTTISH MARKET?VALUE IN HEALTHIF62015-05-010OAAI
IMPLEMENTATION OF NICE CLINICAL GUIDELINES (CG) - WHAT CAN BE LEARNED FROM A UK CASE STUDY AND HOW TO ENSURE THAT HEALTH SERVICES DO NOT FALL SHORT OF THEIR OBLIGATIONSVALUE IN HEALTHIF62015-05-010OAAI
HOW ARE TOPICS SELECTED AND PRIORITIZED BY THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE (NICE) AND WHAT MIGHT BE THE OPTIONS IF A TECHNOLOGY IS NOT SELECTED?VALUE IN HEALTHIF62015-05-010OAAI
TREND ANALYSIS OF SMC DECISIONS - WHAT FACTORS INFLUENCE THE LIKELIHOOD OF POSITIVE, RESTRICTED AND NEGATIVE RECOMMENDATIONS?VALUE IN HEALTHIF62015-05-010OAAI
WILL FLAT EU PRICING BECOME A REALITY? CONSIDERATIONS FOR THE BIOPHARMA INDUSTRY AND WHETHER FUTURE EU PRICING TRANSPARENCY RULES WILL AFFECT THE CURRENT POSITIONVALUE IN HEALTHIF62015-05-010OAAI
Alstrom syndrome: further evidence for linkage to human chromosome 2p13HUMAN GENETICSIF3.61999-11-1539PREAI
Homozygosity mapping of Alstrom syndrome to chromosome 2pHUMAN MOLECULAR GENETICSIF3.21997-02-0164OAAI